Skip to main content
. 2023 Sep 8;18(9):e0291259. doi: 10.1371/journal.pone.0291259

Fig 2. Proportions of patients with potential PASC symptoms*.

Fig 2

*Proportions reflect a cross-sectional assessment of symptoms during follow-up as baseline measurements were not available to assess longitudinal changes.